HLN

Haleon

Healthcare Drug Manufacturers - Specialty & Generic NYSE

About the company

Haleon PLC, a renowned consumer healthcare company, is dedicated to providing a wide array of personal healthcare products. With a global presence, the company operates in five distinct consumer healthcare categories, catering to the diverse needs of individuals worldwide. These categories include Oral Health, Pain Relief, VMS (Vitamins, Minerals, and Supplements), Respiratory Health, and Digestive Health and Other. The company's operations span across multiple continents, with its reportable and geographical segments consisting of North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm), and the Asia Pacific (APAC) region. Each segment represents a vital market for Haleon PLC, contributing significantly to its overall revenue. Although the company experiences success across all segments, the EMEA and LatAm regions stand out as the primary revenue generators. EMEA, which encompasses Europe, the Middle East, and Africa, presents a vast market potential due to its diverse consumer base and established healthcare infrastructure. Haleon PLC has strategically penetrated these markets, offering quality products that address specific regional needs and preferences. Latin America, another significant revenue-generating segment for Haleon PLC, is a dynamic and rapidly growing market. The expanding middle class, rising disposable incomes, and increasing consumer awareness and demand for personal healthcare products have fueled the company's success in this region. Reverse-engineering the achievements of Haleon PLC in these regions reveals a combination of strategic initiatives and market adaptability. The company has focused on tailoring its product offerings to meet the unique requirements of each region's diverse consumer population. This customer-centric approach has allowed Haleon PLC to establish a strong foothold and brand presence in EMEA and LatAm. In terms of product categories, Haleon PLC's Oral Health segment has consistently performed well across all geographies. With a dedication to improving oral care, the company has introduced innovative products such as toothpaste, toothbrushes, mouthwashes, and dental floss. These offerings have resonated with consumers globally, contributing to the significant revenue generated by the Oral Health category. Pain Relief is another core category in Haleon PLC's portfolio, addressing the growing demand for effective solutions to alleviate pain and discomfort. The company provides a diverse range of pain relief products, including analgesics, topical creams, and patches, catering to different types of pain and consumer preferences. The VMS category is essential for Haleon PLC, given the increasing focus on health and well-being by consumers worldwide. With a wide range of vitamins, minerals, and supplements under its portfolio, the company ensures that individuals have access to high-quality products to support their nutritional needs and promote overall wellness. Haleon PLC recognizes the growing concerns surrounding respiratory health and offers several solutions to address respiratory issues. From inhalers to nasal sprays and cough syrups, the Respiratory Health category plays a crucial role in the company's success, particularly in regions where respiratory issues are prevalent. Lastly, Haleon PLC's Digestive Health and Other category includes products aimed at improving digestive well-being. These offerings encompass antacids, probiotics, laxatives, and other remedies to enhance digestive health, providing relief from common issues such as indigestion, bloating, and constipation. In conclusion, Haleon PLC's global presence and diversified product portfolio enable it to meet the personal healthcare needs of consumers across various regions. With a strong emphasis on customer-centricity, tailored product offerings, and strategic market penetration, the company continues to achieve remarkable success, particularly in the revenue-generating regions of EMEA and LatAm. As Haleon PLC continues to innovate and expand its reach, it remains committed to improving the health and well-being of individuals worldwide through its high-quality consumer healthcare products.

Website: https://www.haleon.com

Data updated: June 2, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Healthcare · 1346 peers in sector

Metric HLN Sector median Vs. industry
P/E 17.68 20.10 ↓ Below average
EPS 0.50 USD -1.14 USD ↑ Above average
Dividend yield 2.13% 0.00% ↑ Above average
Profit margin 15.11% 0.00% ↑ Above average
ROE 10.27% -58.84% ↑ Above average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is Haleon?
Haleon PLC, a renowned consumer healthcare company, is dedicated to providing a wide array of personal healthcare products. With a global presence, the company operates in five distinct consumer healthcare categories, catering to the diverse needs of individuals worldwide. These categories include Oral Health, Pain Relief, VMS (Vitamins, Minerals, and Supplements), Respiratory Health, and Digestive Health and Other. The company's operations span across multiple continents, with its reportable and geographical segments consisting of North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm), and the Asia Pacific (APAC) region. Each segment represents a vital market for Haleon PLC, contributing significantly to its overall revenue. Although the company experiences success across all segments, the EMEA and LatAm regions stand out as the primary revenue generators. EMEA, which encompasses Europe, the Middle East, and Africa, presents a vast market potential due to its diverse consumer base and established healthcare infrastructure. Haleon PLC has strategically penetrated these markets, offering quality products that address specific regional needs and preferences. Latin America, another significant revenue-generating segment for Haleon PLC, is a dynamic and rapidly growing market. The expanding middle class, rising disposable incomes, and increasing consumer awareness and demand for personal healthcare products have fueled the company's success in this region. Reverse-engineering the achievements of Haleon PLC in these regions reveals a combination of strategic initiatives and market adaptability. The company has focused on tailoring its product offerings to meet the unique requirements of each region's diverse consumer population. This customer-centric approach has allowed Haleon PLC to establish a strong foothold and brand presence in EMEA and LatAm. In terms of product categories, Haleon PLC's Oral Health segment has consistently performed well across all geographies. With a dedication to improving oral care, the company has introduced innovative products such as toothpaste, toothbrushes, mouthwashes, and dental floss. These offerings have resonated with consumers globally, contributing to the significant revenue generated by the Oral Health category. Pain Relief is another core category in Haleon PLC's portfolio, addressing the growing demand for effective solutions to alleviate pain and discomfort. The company provides a diverse range of pain relief products, including analgesics, topical creams, and patches, catering to different types of pain and consumer preferences. The VMS category is essential for Haleon PLC, given the increasing focus on health and well-being by consumers worldwide. With a wide range of vitamins, minerals, and supplements under its portfolio, the company ensures that individuals have access to high-quality products to support their nutritional needs and promote overall wellness. Haleon PLC recognizes the growing concerns surrounding respiratory health and offers several solutions to address respiratory issues. From inhalers to nasal sprays and cough syrups, the Respiratory Health category plays a crucial role in the company's success, particularly in regions where respiratory issues are prevalent. Lastly, Haleon PLC's Digestive Health and Other category includes products aimed at improving digestive well-being. These offerings encompass antacids, probiotics, laxatives, and other remedies to enhance digestive health, providing relief from common issues such as indigestion, bloating, and constipation. In conclusion, Haleon PLC's global presence and diversified product portfolio enable it to meet the personal healthcare needs of consumers across various regions. With a strong emphasis on customer-centricity, tailored product offerings, and strategic market penetration, the company continues to achieve remarkable success, particularly in the revenue-generating regions of EMEA and LatAm. As Haleon PLC continues to innovate and expand its reach, it remains committed to improving the health and well-being of individuals worldwide through its high-quality consumer healthcare products.
Are Haleon shares expensive?
The price-to-earnings (P/E) ratio of Haleon is 17.68 — the share price is 17.68 times the annual profit per share. That is lower than the typical company in the same industry (industry median: 20.10). This is information, not a recommendation. (as of 2026-06-02)
How big is Haleon?
The market capitalization of Haleon — the combined value of all its shares — is 39.10 B USD. The higher the market cap, the larger the company. (as of 2026-06-02)
Does Haleon pay dividends?
The dividend yield of Haleon is 2.13% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)
What sector does Haleon belong to?
Haleon operates in the Healthcare sector, industry: Drug Manufacturers - Specialty & Generic.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120